(Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that a new research ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
(MENAFN- GlobeNewsWire - Nasdaq) Study published in leading critical care journal shows that higher AI-detected seizure burden is associated with increased odds of disability, further demonstrating ...
The trial of Fintepla in Dravet Syndrome and LGS was run by researchers at the Brno Epilepsy Centre in Czechia.
CeriBell, Inc. (NASDAQ:CBLL) is among the Best Brain-Computer Interface Stocks. On June 8, CeriBell, Inc. (NASDAQ:CBLL) ...
Insillico Medicine and SK Biopharmaceuticals have teamed up on an AI-enabled search for drug candidates targeting neuroimmune ...
Mandisa Glover is sharing the quiet changes she noticed in her father, Danny Glover, in the years before he was diagnosed ...
The number of illegal fireworks are growing and it's lucrative for organized crime ...
On May 10, Bloomberg reported that brain-computer interfaces are transitioning from experimental to early implementation, ...
Precision neurostimulation leverages AI and closed-loop feedback, delivering tailored treatments for neurological disorders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results